Education
About Us
Working with TipRanks
Follow Us
Solara Active Pharma Sciences Ltd. (IN:SOLARA)
:SOLARA
Total Valuation
Solara Active Pharma Sciences Ltd. has a market cap or net worth of ₹24.90B. The enterprise value is ₹46.81B.
Market Cap₹24.90B
Enterprise Value₹46.81B
Share Statistics
Solara Active Pharma Sciences Ltd. has 48.05M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding48.05M
Owned by Insiders
Owned by Instutions
Financial Efficiency
Solara Active Pharma Sciences Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Solara Active Pharma Sciences Ltd. is ―. Solara Active Pharma Sciences Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Solara Active Pharma Sciences Ltd. had revenue of ₹13.00B and earned -₹5.61B in profits. Earnings per share was -₹150.13.
Revenue₹13.00B
Gross Profit₹3.17B
Operating Income-₹1.72B
Pretax Income-₹4.73B
Net Income-₹5.61B
EBITDA-2.59B
Earnings Per Share (EPS)-150.13
Cash Flow
In the last 12 months, operating cash flow was ₹1.04B and capital expenditures ₹0.00, giving a free cash flow of ₹1.04B billion.
Operating Cash Flow₹1.04B
Free Cash Flow₹1.04B
Free Cash Flow per Share₹21.71
Dividends & Yields
Solara Active Pharma Sciences Ltd. pays an annual dividend of ₹2.76, resulting in a dividend yield of
Dividend Per Share₹2.76
Dividend Yield
Payout Ratio
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.48
52-Week Price Change18.79%
50-Day Moving Average504.73
200-Day Moving Average652.10
Relative Strength Index (RSI)51.48
Average Volume (3m)9.69K
Important Dates
Solara Active Pharma Sciences Ltd. upcoming earnings date is May 9, 2025, TBA.
Last Earnings DateJan 24, 2025
Next Earnings DateMay 9, 2025
Ex-Dividend DateAug 18, 2021
Financial Position
Solara Active Pharma Sciences Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Solara Active Pharma Sciences Ltd. has paid ₹1.15B in taxes.
Income Tax₹1.15B
Effective Tax Rate―
Enterprise Valuation
Solara Active Pharma Sciences Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Solara Active Pharma Sciences Ltd. has ₹86.00M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹86.00M billion.
Cash & Marketable Securities₹86.00M
Total Debt₹0.00
Net Cash-₹86.00M
Net Cash Per Share-₹1.79
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Solara Active Pharma Sciences Ltd. is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast